Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels.

MLA

Habeichi, Nada J., et al. “Nicotinamide Riboside: A Promising Therapy for MI-Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase-Mediated NAD Levels.” BioRxiv : The Preprint Server for Biology, Sept. 2024. EBSCOhost, https://doi.org/10.1101/2024.09.05.611567.

APA

Habeichi, N. J., Amin, G., Boitard, S., Tannous, C., Ghali, R., Momken, I., Diab, R., Booz, G. W., Mericskay, M., & Zouein, F. A. (2024). Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels. BioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2024.09.05.611567

Chicago

Habeichi, Nada J, Ghadir Amin, Solene Boitard, Cynthia Tannous, Rana Ghali, Iman Momken, Reine Diab, George W Booz, Mathias Mericskay, and Fouad A Zouein. 2024. “Nicotinamide Riboside: A Promising Therapy for MI-Induced Acute Kidney Injury by Upregulating Nicotinamide Phosphoribosyltransferase-Mediated NAD Levels.” BioRxiv : The Preprint Server for Biology, September. doi:10.1101/2024.09.05.611567.